Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies

Cheng L., Wu S., Zhang K., Qing Y., Xu T.

Narrative Review, published in J Ovarian Res (2017) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
J Ovarian Res (2017)
Reported sample size
—
Source database
Europe PMC
PMID
29100532
PMCID
PMC5670635
DOI
10.1186/s13048-017-0368-6
Citations
58

Abstract (original English)

Exosomes are nanoparticles(40-100 nm) secreted by most cells in the body, which can be isolated from several types of extracellular fluids. It has been shown that exosomes play a key role in intercellular communication and in transportation of genetic information. Emerging evidence shows that exosomes are mediators of metastasis in tumour cells, stromal cells and the extracellular matrix component through the shuttling of cargo, such as proteins, lipids, RNAs, double-stranded DNAs, non-transcribed RNAs, and microRNAs. This phenomenon has been indicated in both tumourigenesis and drug resistance. In this review, we introduce new methods of exosome extraction, focusing on the emerging role of exosomes in ovarian cancer, and discuss their potential clinical applications.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsHumansOvarian NeoplasmsNeoplasm MetastasisDisease ProgressionMicroRNAsBiological TransportFemaleCell-Derived MicroparticlesExosomes

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.